HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 275 filers reported holding HAEMONETICS CORP in Q3 2019. The put-call ratio across all filers is 2.28 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $999,000 | +8.5% | 7,920 | +3.4% | 0.02% | +4.3% |
| Q2 2019 | $921,000 | +37.5% | 7,656 | 0.0% | 0.02% | +35.3% |
| Q1 2019 | $670,000 | -9.5% | 7,656 | +3.6% | 0.02% | -19.0% |
| Q4 2018 | $740,000 | -12.6% | 7,392 | 0.0% | 0.02% | +5.0% |
| Q3 2018 | $847,000 | +63.8% | 7,392 | +28.2% | 0.02% | +53.8% |
| Q2 2018 | $517,000 | +22.5% | 5,764 | 0.0% | 0.01% | +18.2% |
| Q1 2018 | $422,000 | +26.0% | 5,764 | 0.0% | 0.01% | +22.2% |
| Q4 2017 | $335,000 | +56.5% | 5,764 | +20.7% | 0.01% | +50.0% |
| Q3 2017 | $214,000 | +26.6% | 4,774 | +11.3% | 0.01% | +20.0% |
| Q2 2017 | $169,000 | +79.8% | 4,290 | +85.7% | 0.01% | +66.7% |
| Q1 2017 | $94,000 | +1.1% | 2,310 | 0.0% | 0.00% | 0.0% |
| Q4 2016 | $93,000 | – | 2,310 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nitorum Capital, L.P. | 413,122 | $16,608,000 | 4.78% |
| Altalis Capital Management LLC | 88,055 | $3,540,000 | 3.97% |
| RUTABAGA CAPITAL MANAGEMENT LLC/MA | 513,619 | $20,647,000 | 3.54% |
| Black Creek Investment Management Inc. | 1,118,613 | $44,968,000 | 3.46% |
| HealthCor Management, L.P. | 1,150,000 | $46,230,000 | 2.61% |
| Van Berkom & Associates Inc. | 1,136,971 | $45,706,000 | 1.83% |
| AMERICAN CAPITAL MANAGEMENT INC | 567,896 | $22,829,000 | 1.77% |
| FULLER & THALER ASSET MANAGEMENT, INC. | 2,062,539 | $82,914,000 | 1.25% |
| Legato Capital Management LLC | 1,336 | $53,707,000 | 0.97% |
| HEARTLAND ADVISORS INC | 351,314 | $14,123,000 | 0.78% |